Hara Hisashi, Takahashi Tsuyoshi, Miyazaki Yasuhiro, Kurokawa Yukinori, Yamasaki Makoto, Miyata Hiroshi, Nakajima Kiyokazu, Takiguchi Shuji, Mori Masaki, Doki Yuichiro
Dept. of Gastroenterological Surgery, Graduate School of Medicine, Osaka Universicty.
Gan To Kagaku Ryoho. 2014 Nov;41(12):2399-401.
A male patient in his 40s presented with abdominal pain and mass palpitation. He was diagnosed with a submucosal gastric tumor and referred to our clinic. Computed topography (CT) scan revealed a large gastric tumor and multiple hepatic metastases. He was diagnosed with unresectable gastrointestinal stromal tumor (GIST) and began imatinib treatment. However, 2 weeks later, the patient developed a high fever and abdominal pain. Tumor necrosis and abscess formation was observed on the CT scan. We performed emergency surgery, which comprised partial gastrectomy, distal pancreatectomy, and splenectomy, combined with radiofrequency ablation (RFA) for the hepatic metastases. Subsequently, he continued imatinib therapy. However, a new lesion developed in the liver and was diagnosed as imatinib-resistant disease. The new lesion was treated with RFA. Eight years after the treatment, a new lesion occurred in the liver, which was difficult to excise owing to the location. Accordingly, a right-hepatic lobectomy was performed. Currently, he is alive and continues on imatinib therapy.
一名40多岁的男性患者出现腹痛和腹部肿块。他被诊断为胃黏膜下肿瘤,并转诊至我院。计算机断层扫描(CT)显示一个大的胃肿瘤和多处肝转移。他被诊断为不可切除的胃肠道间质瘤(GIST),并开始接受伊马替尼治疗。然而,2周后,患者出现高热和腹痛。CT扫描观察到肿瘤坏死和脓肿形成。我们进行了急诊手术,包括胃部分切除术、远端胰腺切除术和脾切除术,并对肝转移灶进行了射频消融(RFA)。随后,他继续接受伊马替尼治疗。然而,肝脏出现了一个新病灶,被诊断为伊马替尼耐药疾病。新病灶接受了RFA治疗。治疗8年后,肝脏出现了一个新病灶,因其位置难以切除。因此,进行了右肝叶切除术。目前,他还活着并继续接受伊马替尼治疗。